Overview
Founded in 2013 in Ghent (originally under the name AgroSavfe) as a spinoff of Flanders Institute for Biotechnology, Biotalys develops protein-based biocontrol products for crop protection. Its AGROBODY technology platform uses engineered proteins derived from camelid antibody fragments to target crop pests and pathogens with high specificity, offering an alternative to conventional chemical pesticides.
Biotalys is listed on Euronext Brussels and has raised EUR 61M or more in total capital to advance its product pipeline through regulatory approval and toward commercial launch. Biocontrol sits at the intersection of regulatory pressure on chemical pesticides, farm profitability, and growing consumer demand for residue reduction in food.
As a Flanders Institute for Biotechnology spinoff based in Ghent, Biotalys is part of a cluster that includes Protealis and reflects Ghent's position as Belgium's leading agricultural biotech hub.
Funding & milestones
2 events found for Biotalys · 2019–2020
Series CVenture / equity1 sourceEUR 35M
Reported amount EUR 35,000,000
Company-issued release confirms €35m first closing under former name AgroSavfe.
Series c extensionVenture / equity1 sourceEUR 10M
Reported amount EUR 10,000,000
Second close adds €10m, taking combined C to €45m; only incremental amount recorded.
InvestorsNovalis LifeSciences
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Key people
In the news
- Trends TV currently runs an item on Biotalys' innovative technology to develop biobased crop protection products. Our scientists explain the value and the key principles of the AGROBODY® technology to come to protein-based products that are safe, sustainable and effective tools for growers. 🧪 Starring Carlo Boutton, Hélène Notredame and Rebecca De Cauwer.🌟 Click here for the video: https://lnkd.in/equFvVGV or watch it in the loop on Trends Z: https://lnkd.in/e-2Jyf2W until Monday evening 14 September 2026.
- Join our CEO Carlo Boutton and many other scientists and entrepreneurs for a session on bringing innovations to market, live in the Wintercircus Ghent on 27 October 2026. Register here: https://lnkd.in/ec3KpVi6
- Know what? Your research won't turn itself into a company. 🤯 That's why Biovia is joining VIB and Wintercircus Ghent for 𝗙𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗠𝗮𝗿𝗸𝗲𝘁, a free, hands-on session built for PhDs, postdocs, masters, #entrepreneurs and early #spinoffs ready to take the step from research to company. Lessons straight from the horse's mouth 🐴 🎤 Jorn Vanysacker (100IN) 🎤 Carlo Boutton (Biotalys) 🎤 Christel Menet (Confo Therapeutics) 🎤 Wim Van Criekinge (Ghent University) 🎤 Annick Verween (VIB) 🪩 And if you want to keep the
- We are very pleased to announce today that the California Department of Pesticide Regulation (CDPR) has granted state #registration for #EVOCA®, our first protein-based biofungicide. The approval follows the successful completion of the public consultation process earlier in July and confirms that the product has successfully met the state's stringent regulatory requirements for human #health, environmental #safety and product #efficacy. Carlo Boutton, Chief Executive Officer of Biotalys, commented: "This California registration
- Biotalys ontvangt productregistratie in Californië voor EVOCA(ABM FN) Biotalys heeft van het California Department of Pesticide Regulation een staatsregistratie ontvangen voor EVOCA, het eerste eiwitgebaseerde biofungicide van het bedrijf. Dit maakte Biotalys woensdagochtend bekend. De goedkeuring volgt op de succesvolle afronding van het openbare raadplegingsproces eerder in juli en bevestigt dat EVOCA voldoet aan de strenge regelgevingsvereisten van de staat op het … The post Biotalys ontvangt productregistratie in Californië voor EVOCA appeared first o
Trends · 2 Sept 2026
- Biotalys: gestage vooruitgang met EvocaHet Gentse agrobiotechbedrijf Biotalys heeft een bewogen eerste jaarhelft achter de rug. The post Biotalys: gestage vooruitgang met Evoca appeared first on Trends.be.
- Biofungicide Evoca van agrotechbedrijf Biotalys is genomineerd voor de prestigieuze #BernardBlum Award 2026. Die wordt uitgereikt door de IBMA – International Biocontrol Manufacturers Association – aan het meest innovatieve biocontroleproduct van het jaar. Biotalys, met PMV als aandeelhouder, ontwikkelt biologische gewasbeschermers. Evoca is het belangrijkste product van het bedrijf. Eind 2025 kreeg het groen licht voor de Amerikaanse markt. Evoca bestrijdt botrytis, een grauwe schimmel die voorkomt bij o.a. aardbeien, tomaten en
- In case you missed it during the holiday period: trade magazine GPN-Greenhouse Product News ran an article on the increase of #biological crop protection solutions in pest management programs, while positioning Biotalys as one of the key #innovators in the field. Many thanks to Keith Loria for speaking with our CEO Carlo Boutton. https://lnkd.in/gtvEybYR
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.